BACKGROUND Levonorgestrel-releasing intrauterine devices (LNG-IUD) are commonly used for contraception and other indications in many countries. National pharmacovigilance centres have been receiving reports from healthcare professionals and patients of uterine perforation associated with the use of these LNG-IUDs. METHODS National pharmacovigilance centres in the Netherlands, New Zealand, Swi...

OBJECTIVE This study was designed to evaluate the potential usefulness of the levonorgestrel-releasing intrauterine device (LNG - IUD ; Mirena) in treating women with uterine myomas. DESIGN Prospective before-and-after (comparing) study. SETTING Department of Obstetrics and Gynecology King Chulalongkorn Memorial Hospital. SUBJECTS Sixteen women with uterine myomas who intended to receive ...

OBJECTIVE The purpose of this paper is to review the experience with the frameless, anchored, GyneFix copper-releasing intrauterine contraceptive devices (IUCDs/IUDs) (Contrel Europe, Belgium), and to demonstrate their high acceptability and low rate of discontinuation of use, which could contribute to current efforts that aim to reduce radically the high number of unintended pregnancies and in...

OBJECTIVE To investigate the incidence of actinomyces-like organisms in routine cervical smears of Korean women and to evaluate its association with the development of pelvic inflammatory disease (PID) in these women. METHODS The results of cervical smears between 2011 and 2012 at a single university hospital were searched. If positive for actinomyces-like organisms, the medical record of the...

OBJECTIVE Presentation of the diagnostic and surgical treatment methods of our extrauterine intrauterine device (IUD) cases. MATERIAL AND METHODS We retrospectively evaluated the data of 21 extrauterine IUD cases at our clinic between 2008 and 2010. The symptoms, diagnostic methods, and surgical treatments were evaluated. RESULTS A total of 14 copper and seven levonorgestrel (LNG) IUDs were...

Objectives: To examine the differences in sexual functions between women using copper intrauterine device (Cu-IUD) and levonorgestrel system (LND-IUS). Methods: A total of 125 ages 20 40 were included study. The demographic data all participants recorded. Female Sexual Function Index (FSFI) was performed to participants. Study divided into 3 groups; 42 Cu-IUD users, LND-IUS 41 control (not use ...

Introduction: Uterine perforation with an intra-abdominal intrauterine device (IUD) resulting in consultation to a general surgeon is rare. However, migrated IUD due to uterine perforation, regardless of the severity of symptoms, should be promptly removed surgically to avoid further bowel perforation or obstruction. We report a case of intra-abdominal IUD utilizing laparoscopic removal. Case: ...

INTRODUCTION The last decade of the usage of intrauterine contraception has been marked by the application of levonorgestrel-releasing hormonal devices. A hormonal intrauterine device (IUD) releases a certain amount of progestogen, whose effect on endometrium is such that, apart from preventing unwanted pregnancy, also regulates the menstrual bleeding by reducing the quantity and the duration o...

I read with interest the letter by Webb et al. about the pitfalls of adapting the Clinical Effectiveness Unit’s guidance on emergency contraception (EC). Their letter discusses, in relation to maximising the pharmacodynamic attributes of ulipristal acetate (UA), the significant inaccuracies inherent in the calculation of the timing of ovulation based on the menstrual history. However, we freque...

OBJECTIVE This study was conducted to evaluate the effect of a miniaturized frameless copper IUD (GyneFix 200 small) and a copper-levonorgestrel (GynePlant) intrauterine system (IUS) on the amount of menstrual blood loss (MBL). METHODS In 60 Belgian women using GyneFix 200 and 21 using GynePlant, MBL was assessed with the visual assessment technique. RESULTS MBL scores in GyneFix 200 users ...